Transforming procurement with AstraZeneca

AstraZeneca was sitting on legacy Procure-to-Pay (P2P) technology that was no longer fit for its rapid growth and the breadth of goods and suppliers that it needed to manage. The pharmaceutical giant needed a trusted partner to transform it’s $9 billion procurement system across 11 countries, with 35,00 users and over 20,000 suppliers.

With this challenge in mind, we conducted a comprehensive assessment on how ready AstraZeneca was to embark on this change. It quickly became clear that delivering a step change in user experience was a key priority and Coupa’s leading Procure-to-Pay platform was selected to help enable this transformation.

A core goal of the transformation programme was to align ways of working across functions and geographies into a single standardised model and way to buy. The key design principles we worked towards were:

• User experience is paramount to the design
• Supplier engagement and simplicity is a priority
• Adopt not adapt - no customisation of best practice technology
• A single standardised global core design
• Enabling the value of world class procurement

Read our client story to find out how we future proofed the Procure-to-Pay process, built learning pathways for stakeholders and the benefits for end users, suppliers, finance, IT and procurement.